Synthesis and antiproliferative activity of unnatural enantiomers of 7-epi-goniofufurone and crassalactone C

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 19, 2008, Pages 5178-5181

  Popsavin, Velimir ^a   Benedeković, Goran ^a   Srećo, Bojana ^a   Popsavin, Mirjana ^a   Francuz, Jovana ^a   Kojić, Vesna ^b   Bogdanović, Gordana ^b  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b Institute of Oncology Sremska Kamenica   (Yugoslavia)

Author keywords

7 Epigoniofufurone; Antitumor agents; Crassalactone C; d Xylose; Goniofufurone; Stereocontrolled syntheses; Styryl lactones; Unnatural enantiomers

Indexed keywords

7 EPI GONIOFUFURONE; CRASSALACTONE C; DOXORUBICIN; LACTONE DERIVATIVE; NATURAL PRODUCT; UNCLASSIFIED DRUG; XYLOSE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SYNTHESIS; ENANTIOMER; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

ANNONACEAE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG SCREENING ASSAYS, ANTITUMOR; HELA CELLS; HUMANS; JURKAT CELLS; LACTONES; MOLECULAR STRUCTURE; PLANTS, MEDICINAL; STEREOISOMERISM; TUMOR CELLS, CULTURED; XYLOSE;

EID: 52349106525     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.08.093     Document Type: Article

References (31)

1. Fang X.P., Anderson J.E., Chang C.J., McLaughlin J.L., and Fanwick P.E. J. Nat. Prod. 54 (1991) 1034
2. Shing T.K.M., Tsui H.-C., and Zhou Z.-H. Tetrahedron 48 (1992) 8659
3. Shing T.K.M., and Tsui H.-C. J. Chem. Soc. Chem. Commun. (1992) 432
4. For reviews on biological activity of natural styryl lactones and analogues, see:. de Fatima A., Modolo L.V., Conegero L.S., Pilli R.A., Ferreira C.V., Kohn L.K., and de Carvalho J.E. Curr. Med. Chem. 13 (2006) 3371
5. Mye{cyrillic}reyala H.B., and Joe M. Curr. Med. Chem. Anti-Cancer Agents 1 (2001) 293
6. Blazquez M.A., Bermejo A., Zafra-Polo M.C., and Cortes D. Phytochem. Anal. 10 (1999) 161
7. For recent reviews on the synthesis of styryl lactones, see:. Mondon M., and Gesson J.-P. Curr. Org. Synth. 3 (2006) 41
8. Zhao G., Wu B., Wu X.Y., and Zhang Y.Z. Mini-Rev. Org. Chem. 2 (2005) 333
9. Kapitán P., and Gracza T. Tetrahedron: Asymmetry 19 (2008) 38
10. Prasad K.R., and Gholap S.L. J. Org. Chem. 73 (2008) 2
11. Yadav K.V., and Agrawal D. J. Chem. Soc. Chem. Commun. (2007) 5232 and references therein
12. Tuchinda P., Munyoo B., Pohmakotr M., Thinapong P., Sophasan S., Santisuk T., and Reutrakul V. J. Nat. Prod. 69 (2006) 1728
13. Popsavin V., Benedeković G., Srećo B., Popsavin M., Francuz J., Kojić V., and Bogdanović G. Org. Lett. 9 (2007) 4235
14. de Fatima A., Kohn L.K., de Carvalho J.E., and Pilli R.A. Bioorg. Med. Chem. 14 (2006) 622
15. Liu S., Kulp S.K., Sugimoto Y., Jiang J., Chang H.-L., Dowd M.K., Wan P., and Lin Y.C. Anticancer Res. 22 (2002) 33
16. Boger D.L., and Hong J. J. Am. Chem. Soc. 123 (2001) 8515
17. Nishimura Y., Umezawa Y., Adachi H., Kondo S., and Takeuchi T. J. Org. Chem. 61 (1996) 480
18. Su Y.-L., Yang C.-S., Teng S.-J., Zhao G., and Ding Y. Tetrahedron 57 (2001) 2147
19. Gracza T., and Jäger V. Synthesis (1994) 1359
20. Gracza T., and Jäger V. Synlett (1992) 191
21. Prakash K.R.C., and Rao S.P. Tetrahedron Lett. 32 (1991) 7473
22. Popsavin V., Krstić I., Popsavin M., Srećo B., Benedeković G., Kojić V., and Bogdanović G. Tetrahedron 62 (2006) 11044
23. Popsavin M., Popsavin V., Vukojević N., and Miljković D. Collect Czech. Chem. Commun. 59 (1994) 1884
24. Jones G.H., and Moffat J.G. Methods Carbohydr. Chem. 6 (1972) 315
25. Valverde S., Martin-Lomas M., Herradon B., and Garcia-Ochoa S. Tetrahedron 43 (1987) 1895
26. ++Na).
27. 2 synthesis: 10 steps and 12% overall yield.
28. Mitsunobu O. Synthesis (1981) 1
29. 6: 403.1152.
30. 4: 233.0808.
31. Cytotoxic activities were evaluated by using standard MTT assay after exposure of cells to the tested compounds for 72 h. Results are presented as mean values of three independent experiments done in quadriplicates. Coefficients of variation were <10%.